biotech · Obesity
Timmune Biotech
Timmune Biotech is a biotech organization headquartered in CN. Primary therapeutic focus areas include Obesity. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from pu
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 0
- Patents
- 0
ALT-801
Phase 1 · small molecule · Obesity
ALT-801 for Obesity is a Phase 1 program (small_molecule) at Timmune Biotech with 1 ClinicalTrials.gov record(s).
Internal code ALT-801-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Timmune Biotech
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Obesity
- Status
- completed
- Trials
- 1